<HashMap><database>EGA</database><scores/><additional><omics_type>Genomics</omics_type><technology_type>450K</technology_type><study_type>Other</study_type><full_dataset_link>https://ega-archive.org/studies/EGAS00001002169</full_dataset_link><host>EGA</host><description>EGA study EGAS00001002169</description><dataset_title>MeDALL epigenetics data</dataset_title><repository>EGA</repository><category>restricted</category><description_synonyms>(E)-4, European Economic Community, Common Markets, (E)-3, 4-bis(4-hydroxyphenyl)-3-hexene, exercise induced asthma, single-organism developmental process, Mite, Common Market, Incidences, Reactive airway disease, postnatal development, number, des, Person-time Rates, Proportion, growth and development, Normalcies, presence, Asthmas, prevention, Secondary Attack Rate, Rate, trans-4, Asthma, European Coal and Steel Community, Impacts, 4, Incidence Rate, Allergic Reactions, Financing, Bronchial Asthma, Environmental Impacts, Epidemiologies, Attack Rates, prevention and control, Hypersensitivities, European Common Market, European Economic, Normalities, average, Community Financing, study, occurrence, 4'-(1, Allergic, Union, Economic Community, prevalence, VLDLRCH, exercise-induced asthma, DmelCG9078, Acarus, European Communities, Social, Social Epidemiology, preventive measures, Environmental Impact, Cumulative, chronic obstructive asthma, Grants, Reaction, Person-time, Person time Rate, des1, cerebellar hypoplasia, 2-diethyl-1, Incidence Proportions, alpha'-diethyl-(E)-4, Distilbene, Economic Communities, chronic obstructive asthma with status asthmaticus, Methylations, nonprogressive, incidence, Allergy, Individual Health, trans-Diethylstilbesterol, Communities, des-1, preventive therapy, European Common Markets, Epidemiology, LGMD2R, Attack Rate, Cumulative Incidence, frequency, Incidence, Secondary Attack, Normalcy, 2-ethenediyl)bisphenol, ASTHMA, Impact, development, EEC, Environmental, Cumulative Incidences, count in organism, Incidence Rates, dietilestilbestrol, Hypersensitivities., l(2)gdh-2, European, Organized Financing, Market, 4'-dihydroxy-alpha, Allergies, Common, VLDLR associated, Individual, methylation, Person-time Rate, outbreaks, cerebellar disorder, beta-diethylstilbene, Allergic Reaction, hypersensitivity, European Economic Communities, with mental retardation, allergic hypersensitivity disease, Ifc, Reactions, DES-1, Normality, CG9078, prophylaxis, postnatal growth, European Atomic Energy Community, chronic obstructive asthma with acute exacerbation, alpha, Euratom, l(2)26Ab, surveillance, morbidity, endemics, European Common, Grant, Secondary, ms(2)04875, Incidence Proportion, Health, European Community, CSM2, control, CSM1, Attack, cardinality, Environments, 4'-stilbenediol, DES, epidemics, diethylstilbestrol, trans-Diethylstilbestrol, diethylstilbestrolum, Secondary Attack Rates, Bronchial, trans-Diethylstilboesterol, growth, Social Epidemiologies, Community</description_synonyms><name_synonyms>study.</name_synonyms></additional><is_claimable>false</is_claimable><name>MeDALL epigenetics study</name><description>MeDALL- (Mechanisms of the Development of ALLergy) is a collaborative project supported by the European Union under the Health Cooperation Work Programme of the 7th Framework programme (grant agreement number 261357).MeDALL epigenetics study includes illumina 450k methylation measurements from 4 cohorts: Infancia y Medio Ambiente (INMA), Etudes des Déterminants pré et postnatals précoces du développement et de la santé de l’ENfant (EDEN), Children’s Allergy Environment Stockholm Epidemiology study(BAMSE), and Prevention and Incidence of Asthma and Mite Allergy (PIAMA)</description><dates><updated>2018-01-17 10:45:46</updated></dates><accession>EGAS00001002169</accession><cross_references><TAXONOMY>9606</TAXONOMY><EGA>EGAD00010001455</EGA><EGA>EGAC00001000578</EGA></cross_references></HashMap>